Düsseldorf, Germany

Martina Klein



 

Average Co-Inventor Count = 9.5

ph-index = 2

Forward Citations = 13(Granted Patents)


Location History:

  • Düsseldorf, DE (2012)
  • Heiligenhaus, DE (2013 - 2015)

Company Filing History:


Years Active: 2012-2015

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Martina Klein: Innovator in Cardiovascular Medicaments

Introduction

Martina Klein is a prominent inventor based in Düsseldorf, Germany. She has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds for the treatment of cardiovascular disorders. With a total of 6 patents to her name, her work has had a substantial impact on the pharmaceutical industry.

Latest Patents

Klein's latest patents include innovative compounds such as substituted 4-aryl-1,4-dihydro-1,6-naphthyridine amides. These compounds are designed for the treatment and/or prophylaxis of diseases, specifically targeting cardiovascular disorders. The applications detail a process for their preparation and their use in the manufacture of medicaments aimed at improving patient outcomes in cardiovascular health.

Career Highlights

Throughout her career, Martina Klein has worked with notable companies in the pharmaceutical sector, including Bayer Intellectual Property GmbH and Bayer Schering Pharma AG. Her experience in these organizations has allowed her to develop her expertise in patentable innovations and contribute to significant advancements in medical treatments.

Collaborations

Klein has collaborated with esteemed colleagues such as Lars Bärfacker and Karl-Heinz Schlemmer. These partnerships have fostered a collaborative environment that has led to the successful development of her patented inventions.

Conclusion

Martina Klein's contributions to the field of medicinal chemistry and her innovative patents underscore her role as a key figure in the development of cardiovascular treatments. Her work continues to influence the pharmaceutical industry and improve health outcomes for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…